Maite Aguillo-Martinez

Irunlarrea St, 3
Pamplona, NC 31008, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Circulating low-density neutrophils as biomarkers of resistance to first-line anti-PD-1/PD-L1 immunotherapy in non-small cell lung cancer.

Circulating low-density neutrophils as biomarkers of resistance to first-line anti-PD-1/PD-L1 immunotherapy in non-small cell lung cancer.

Journal: Translational oncology

Published: January 21, 2026

Long-term survival and biomarkers of immunotherapy in small cell lung cancer: a systematic review.

Long-term survival and biomarkers of immunotherapy in small cell lung cancer: a systematic review.

Journal: Translational lung cancer research

Published: December 15, 2025

Efficacy and safety of lorlatinib in patients with ALK- and ROS1-rearranged metastatic non-small cell lung cancer treated within the compassionate use program in Spain.

Efficacy and safety of lorlatinib in patients with ALK- and ROS1-rearranged metastatic non-small cell lung cancer treated within the compassionate use program in Spain.

Journal: Cancer treatment and research communications

Published: November 03, 2024

Prolonged disease control with local treatments in oligo-acquired resistance to immune-checkpoint inhibitors.

Prolonged disease control with local treatments in oligo-acquired resistance to immune-checkpoint inhibitors.

Journal: Translational lung cancer research

Published: January 30, 2023

Plasma fractalkine contributes to systemic myeloid diversity and PD-L1/PD-1 blockade in lung cancer.

Plasma fractalkine contributes to systemic myeloid diversity and PD-L1/PD-1 blockade in lung cancer.

Journal: EMBO reports

Published: August 01, 2022

Identification of ALK-positive patients with advanced NSCLC and real-world clinical experience with crizotinib in Spain (IDEALK study).

Identification of ALK-positive patients with advanced NSCLC and real-world clinical experience with crizotinib in Spain (IDEALK study).

Journal: Lung cancer (Amsterdam, Netherlands)

Published: July 07, 2022

Circulating Low Density Neutrophils Are Associated with Resistance to First Line Anti-PD1/PDL1 Immunotherapy in Non-Small Cell Lung Cancer.

Circulating Low Density Neutrophils Are Associated with Resistance to First Line Anti-PD1/PDL1 Immunotherapy in Non-Small Cell Lung Cancer.

Journal: Cancers

Published: June 25, 2022

CAR-T Cells for the Treatment of Lung Cancer.

CAR-T Cells for the Treatment of Lung Cancer.

Journal: Life (Basel, Switzerland)

Published: February 23, 2022

Early Detection of Hyperprogressive Disease in Non-Small Cell Lung Cancer by Monitoring of Systemic T Cell Dynamics.

Early Detection of Hyperprogressive Disease in Non-Small Cell Lung Cancer by Monitoring of Systemic T Cell Dynamics.

Journal: Cancers

Published: December 12, 2019

PD-L1 Expression in Systemic Immune Cell Populations as a Potential Predictive Biomarker of Responses to PD-L1/PD-1 Blockade Therapy in Lung Cancer.

PD-L1 Expression in Systemic Immune Cell Populations as a Potential Predictive Biomarker of Responses to PD-L1/PD-1 Blockade Therapy in Lung Cancer.

Journal: International journal of molecular sciences

Published: March 06, 2019

Highly aggresive pulmonary epithelioid hemangioendothelioma: a case report

Highly aggresive pulmonary epithelioid hemangioendothelioma: a case report

Journal: Anales del sistema sanitario de Navarra

Published: August 03, 2017

Clinical management and outcome of patients with advanced NSCLC carrying EGFR mutations in Spain.

Clinical management and outcome of patients with advanced NSCLC carrying EGFR mutations in Spain.

Journal: BMC cancer

Published: June 20, 2016

Showing 1-12 of 13

Last Updated: 09/26/2026